Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FXYD7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NKIRAS1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | NPM3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LRIT3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C11orf68 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MPV17 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | REV1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MSI1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZFYVE28 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CHN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |